DCKA
From Wikipedia, the free encyclopedia
| DCKA | |
|---|---|
|
5,7-dichloro-4-oxo-1H-quinoline-2-carboxylic acid |
|
| Identifiers | |
| CAS number | 131123-76-7 |
| PubChem | 1779 |
| IUPHAR ligand | 2361 |
| Jmol-3D images | Image 1 |
|
|
| Properties | |
| Molecular formula | C10H5Cl2NO3 |
| Molar mass | 258.058 g/mol |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) |
|
| Infobox references |
DCKA (5,7-dichlorokynurenic acid) is a selective NMDA receptor (NMDAR) antagonist acting at the glycine site on the NMDAR complex.[1]
[edit] References
- ^ McNamara D, Smith EC, Calligaro DO, O'Malley PJ, McQuaid LA, Dingledine R. 5,7-Dichlorokynurenic acid, a potent and selective competitive antagonist of the glycine site on NMDA receptors. Neuroscience Letters. 1990 Nov 27;120(1):17-20. PMID 2149877
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

